An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox-Reference-Cited by-同舟云学术

An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox

Published:2023-08 Issue:2 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Tomita Noriko¹^ORCID,Terada-Hirashima Junko¹^ORCID,Uemura Yukari¹^ORCID,Shimizu Yosuke¹^ORCID,Iwasaki Haruka²,Yano Rina¹,Suzuki Tetsuya²^ORCID,Saito Sho²,Okumura Nobumasa²^ORCID,Sugiura Wataru¹,Ohmagari Norio²,Ujiie Mugen²^ORCID

Affiliation:

1. Centre for Clinical Sciences, National Centre for Global Health and Medicine, Tokyo, Japan

2. Disease Control and Prevention Centre, National Centre for Global Health and Medicine, Tokyo, Japan

Funder

Health, Labour and Welfare Administration Promotion Survey Project Grant

Ministry of Health, Labour and Welfare

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2242219

Reference30 articles.

1. World Health Organization. Mpox (monkeypox) outbreak: global trends; 2022 [accessed 2023 Apr 10].: https://worldhealthorg.shinyapps.io/mpx_global/.

2. Human Monkeypox

3. Comprehensive update on the monkeypox outbreak

4. Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans

5. Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines against mpox: MVA-BN and LC16m8;Expert Review of Vaccines;2024-09

2. Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity;Emerging Microbes & Infections;2024-08-16

3. Enhanced Immune Responses in Mice by Combining the Mpox Virus B6R-Protein and Aluminum Hydroxide-CpG Vaccine Adjuvants;Vaccines;2024-07-15

4. Safety and Effectiveness of LC16m8 for Pre-Exposure Prophylaxis against mpox in a High-Risk Population: An Open-Label Randomized Trial;2024-06-07

5. Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections;Nature Communications;2024-05-31